179 related articles for article (PubMed ID: 23229199)
1. Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma.
Liu F; Sun YL; Xu Y; Liu F; Wang LS; Zhao XH
Oncol Rep; 2013 Feb; 29(2):419-24. PubMed ID: 23229199
[TBL] [Abstract][Full Text] [Related]
2. [Expression of stathmin in esophageal squamous cell carcinoma and its biological significance].
Wang F; Wang LX; He W; Zhu LN; Zhao PR; Fan QX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1552-7. PubMed ID: 20650764
[TBL] [Abstract][Full Text] [Related]
3. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
Wang S; Akhtar J; Wang Z
Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
[TBL] [Abstract][Full Text] [Related]
4. Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel.
Feng W; Xiaoyan X; Xuan Y; Xiangke L; Zichang Y; Ran Z; Liuxing W; Qingxia F
Cancer Gene Ther; 2015 Apr; 22(3):115-21. PubMed ID: 25572118
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
Ni PZ; He JZ; Wu ZY; Ji X; Chen LQ; Xu XE; Liao LD; Wu JY; Li EM; Xu LY
Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
[TBL] [Abstract][Full Text] [Related]
6. STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.
Jiang W; Huang S; Song L; Wang Z
Oncol Rep; 2018 Feb; 39(2):834-842. PubMed ID: 29251330
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma.
Wang F; Wang LX; Li SL; Li K; He W; Liu HT; Fan QX
J Surg Oncol; 2011 Jun; 103(7):704-15. PubMed ID: 21360534
[TBL] [Abstract][Full Text] [Related]
8. Rho/ROCK Pathway Regulates Migration and Invasion of Esophageal Squamous Cell Carcinoma by Regulating Caveolin-1.
Liu Z; Yu J; Wu R; Tang S; Cai X; Guo G; Chen S
Med Sci Monit; 2017 Dec; 23():6174-6185. PubMed ID: 29288243
[TBL] [Abstract][Full Text] [Related]
9. Stathmin is a marker of progression and poor prognosis in esophageal carcinoma.
Wang F; Xuan XY; Yang X; Cao L; Pang LN; Zhou R; Fan QX; Wang LX
Asian Pac J Cancer Prev; 2014; 15(8):3613-8. PubMed ID: 24870766
[TBL] [Abstract][Full Text] [Related]
10. STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells.
Akhtar J; Wang Z; Yu C; Li CS; Shi YL; Liu HJ
BMC Cancer; 2014 Jan; 14():28. PubMed ID: 24433541
[TBL] [Abstract][Full Text] [Related]
11. Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients.
Akhtar J; Wang Z; Jiang WP; Bi MM; Zhang ZP
J Gastroenterol Hepatol; 2014 May; 29(5):944-50. PubMed ID: 24372619
[TBL] [Abstract][Full Text] [Related]
12. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p28GANK accelerates the metastasis of oesophageal squamous cell carcinoma.
Tang S; Qin J; Liu W; Zheng X; Wu X; Xu H; Qiao L; Fan Q; Zeng W; Jiang M
Mol Med Rep; 2015 Jun; 11(6):4291-6. PubMed ID: 25634618
[TBL] [Abstract][Full Text] [Related]
15. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
[TBL] [Abstract][Full Text] [Related]
16. [Up-regulation of stathmin induces growth arrest of esophageal squamous cell carcinoma EC9706 cell].
Wang F; Wang LX; He W; Li K; Wang RL; Zhao PR; Fan QX
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2140-4. PubMed ID: 21029632
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
18. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Dishevelled-2 contributes to proliferation and migration of human esophageal squamous cell carcinoma.
Zhou G; Ye J; Sun L; Zhang Z; Feng J
J Mol Histol; 2016 Jun; 47(3):287-95. PubMed ID: 27083564
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
